Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease-Reference-Cited by-同舟云学术

Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease

Published:2016-07 Issue:7 Volume:9 Page:
ISSN:1941-9651
Container-title:Circulation: Cardiovascular Imaging
language:en
Short-container-title:Circ: Cardiovascular Imaging

Author:

Risse Jessie¹,Mandry Damien¹,Settembre Nicla¹,Vigouroux Charlène¹,Claudin Marine¹,Tsintzila Georgia¹,Huttin Olivier¹,Malikov Sergueï¹,Zuily Stéphane¹,Wahl Denis¹

Affiliation:

1. From the Vascular Medicine Division, Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases (J.R., S.Z., D.W.), Departments of Radiology (D.M.), Vascular Surgery (N.S., S.M.), Pathology (C.V.), Nuclear Medicine (M.C.), and Cardiology (O.H.), CHRU de Nancy, France; INSERM, U1116, Nancy, France (J.R., S.Z., D.W.); Lorraine University School of Medicine, Nancy, France (J.R., D.M., N.S., D.W., S.M., S.Z.); France; INSERM, U947, Nancy, France (D.M.); Department of Cardiology, CHR...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference4 articles.

1. Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis

2. Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis

3. Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan

4. Rapid control of disease activity by tocilizumab in 10 ‘difficult-to-treat’ cases of Takayasu arteritis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular Interventions in Takayasu Arteritis;Current Treatment Options in Rheumatology;2024-07-23

2. Chinese guideline for the diagnosis and treatment of Takayasu’s arteritis (2023);Rheumatology and Immunology Research;2024-03-01

3. Comment on: Different treatment options for Takayasu arteritis patients with moderate-to-severe aortic regurgitation: long-term outcomes;Rheumatology;2021-02-22

4. Treatment;Large and Medium Size Vessel and Single Organ Vasculitis;2021

5. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review;Autoimmunity Reviews;2018-04